Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells

Glioblastoma stem-like cells (GSC) are hypothesized to evade current therapies and cause tumor recurrence, contributing to poor patient survival. Existing cell surface markers for GSC are developed from embryonic or neural stem cell systems; however, currently available GSC markers are suboptimal in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zorniak, Michael, Clark, Paul A., Umlauf, Benjamin J., Cho, Yongku, Shusta, Eric V., Kuo, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696472/
https://www.ncbi.nlm.nih.gov/pubmed/29158489
http://dx.doi.org/10.1038/s41598-017-16066-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696472/
https://www.ncbi.nlm.nih.gov/pubmed/29158489
http://dx.doi.org/10.1038/s41598-017-16066-1

Ejemplares similares